Jacques W M Lenders Selected Research

Carotid Body Tumor

6/2004	Cardiovascular responses to stress after carotid baroreceptor denervation in humans.
8/2003	Baroreflex control of muscle sympathetic nerve activity after carotid body tumor resection.
3/2002	Long-term effects of carotid sinus denervation on arterial blood pressure in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacques W M Lenders Research Topics

Disease

38	Pheochromocytoma 01/2022 - 03/2002
32	Neoplasms (Cancer) 01/2022 - 03/2002
24	Hyperaldosteronism (Conn Syndrome) 01/2022 - 09/2009
24	Paraganglioma (Paragangliomas) 03/2021 - 03/2007
20	Hypertension (High Blood Pressure) 02/2022 - 08/2002
10	Adenoma (Adenomas) 01/2020 - 01/2016
8	Hyperplasia 01/2019 - 01/2016
6	Neurofibromatosis 1 (Neurofibromatosis Type I) 08/2014 - 08/2005
6	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2011 - 08/2005
4	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2006
4	Essential Hypertension 01/2019 - 02/2002
4	Chronic Obstructive Pulmonary Disease (COPD) 05/2013 - 01/2012
4	von Hippel-Lindau Disease (von Hippel Lindau Disease) 08/2009 - 02/2005
3	Adrenal incidentaloma 01/2022 - 08/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 01/2012
3	Carotid Body Tumor 06/2004 - 03/2002
3	Hypoxia (Hypoxemia) 11/2003 - 08/2002
2	Hypertensive Crisis 11/2015 - 11/2011
2	Hypotension (Low Blood Pressure) 06/2014 - 01/2004
2	Hypoglycemia (Reactive Hypoglycemia) 05/2004 - 11/2003
1	Residual Neoplasm 02/2022
1	Intraoperative Complications 02/2022
1	Hematuria 02/2022
1	Adrenocortical Carcinoma 01/2022
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Hypertrophy 12/2020
1	Vascular Remodeling 01/2020
1	Disease Progression 08/2019
1	Endocrine System Diseases (Endocrine Diseases) 01/2018
1	Familial Hyperaldosteronism 01/2018
1	Glucocorticoid-Remediable Aldosteronism 01/2018

Drug/Important Bio-Agent (IBA)

38	CatecholaminesIBA 02/2022 - 03/2002
17	AldosteroneIBA 08/2020 - 09/2009
11	SteroidsIBA 01/2022 - 11/2014
11	NormetanephrineIBA 01/2022 - 09/2002
11	MetanephrineIBA 12/2020 - 09/2002
9	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 02/2002
9	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 08/2005
8	Epinephrine (Adrenaline)FDA LinkGeneric 03/2011 - 06/2003
6	3-methoxytyramine (methoxytyramine)IBA 01/2022 - 03/2011
6	Antihypertensive Agents (Antihypertensives)IBA 12/2020 - 12/2006
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2012 - 06/2003
4	EnzymesIBA 01/2021 - 06/2007
4	Biomarkers (Surrogate Marker)IBA 08/2019 - 07/2012
4	Dopamine (Intropin)FDA LinkGeneric 08/2017 - 03/2007
4	Myc associated factor XIBA 11/2014 - 05/2012
3	Cortisone FDA Link 07/2017 - 02/2002
2	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022 - 01/2020
2	Mineralocorticoid Receptor AntagonistsIBA 10/2020 - 01/2016
2	ReninIBA 01/2020 - 01/2019
2	3-Iodobenzylguanidine (Iobenguane)IBA 03/2019 - 06/2007
2	SaltsIBA 12/2018 - 04/2010
2	Cosyntropin (Cortrosyn)FDA LinkGeneric 06/2017 - 11/2015
2	Spironolactone (Aldactone)FDA LinkGeneric 03/2017 - 10/2015
2	ParaffinIBA 06/2015 - 08/2014
2	Proteins (Proteins, Gene)FDA Link 08/2014 - 08/2009
2	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 11/2003
2	Hormones (Hormone)IBA 12/2013 - 11/2003
2	SmokeIBA 05/2013 - 01/2013
2	Bronchodilator Agents (Bronchodilators)IBA 01/2013 - 01/2012
2	Glucagon (Glukagon)FDA Link 01/2010 - 11/2008
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2003 - 08/2002
1	AdrenomedullinIBA 08/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021
1	Dopamine beta-HydroxylaseIBA 01/2021
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 12/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	18-oxocortisolIBA 01/2018
1	18-hydroxycortisolIBA 01/2018
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 07/2017
1	Androstenedione (4 Androstene 3,17 dione)IBA 07/2017
1	Oral ContraceptivesIBA 07/2017
1	CorticosteroneIBA 07/2017
1	Cortodoxone (11 Deoxycortisol)IBA 07/2017
1	Dehydroepiandrosterone (DHEA)IBA 07/2017
1	Desoxycorticosterone (Deoxycorticosterone)IBA 07/2017
1	PregnenoloneIBA 07/2017
1	Progesterone FDA LinkGeneric 07/2017
1	Testosterone (Sustanon)FDA Link 07/2017
1	Dehydroepiandrosterone SulfateIBA 07/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2015
1	GlucocorticoidsIBA 11/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2015
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 06/2015
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 06/2015
1	Peroxidase (Myeloperoxidase)IBA 08/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014
1	SodiumIBA 06/2014
1	Adenosine Triphosphate (ATP)IBA 07/2013
1	Adenosine Diphosphate (ADP)IBA 07/2013
1	Succinic Acid (Succinate)IBA 07/2013
1	Adenosine Monophosphate (AMP)IBA 07/2013
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 07/2013

Therapy/Procedure

13	Adrenalectomy 12/2020 - 02/2012
5	Denervation 06/2004 - 03/2002
3	Therapeutics 10/2020 - 12/2006
2	Radiotherapy 06/2004 - 08/2002
1	Cystectomy 02/2022
1	Renal Dialysis (Hemodialysis) 01/2021